Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort ascending
Job Title Site Location Division Business Functional Area Date Posted Sort ascending
Associate or Manager, PHAD Japan Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 23, 2024
Associate, Country QA Compliance Head Office (Japan) (Pharmaceuticals) Japan Operations Innovative Medicines Quality Oct 22, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 21, 2024
Lead/Associate, CX Content Creation Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 20, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Investigation Expert Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Associate Clinical Project Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Japan Program Head (Neuroscience & GTx) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Japan Program Head (Immunology) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Lead, Integrated Insights & Planning_市場調査 Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 07, 2024
Associate, TA Medical (General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Oct 07, 2024
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 07, 2024
TA Strategy Lead, RLT (Prostate Cancer) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 07, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
CX strategy Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 04, 2024
TA Strategy Lead - GenMed Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 02, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Sep 17, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 12, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Sep 10, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 05, 2024
Group Manager, MSL Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Sep 05, 2024
Project Engineer (Design Phase)_RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Sep 03, 2024
P&O Business Partner Development & Biomedical Research Japan Head Office (Japan) (Pharmaceuticals) Japan People & Organization Innovative Medicines Human Resources Sep 03, 2024
Associate, QA Officer Operations Sasayama Japan Operations Innovative Medicines Quality Sep 03, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 03, 2024
QC Analyst Sasayama Japan Operations Innovative Medicines Quality Sep 03, 2024
Solution Design Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Sep 03, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 29, 2024
Associate/Manager, MSL (Cardiovascular) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 20, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Aug 07, 2024
Technical System Lead (Qualification) Sasayama Japan Operations Innovative Medicines Technical Operations Jul 31, 2024
MS&T Expansion Lead RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Jul 31, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Information Technology Jul 22, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 22, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 18, 2024
Senior Specialist - Automation Engineer Sasayama Japan Operations Research & Development Jul 16, 2024
Associate Director Pipeline Management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Japan Program Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 10, 2024

Pagination

  • 1
  • 2
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia